Novel splice-site mutations as the cause of FAP-related cancer in two families K Sweet, B McIlhatton, V McConnell, W Logan and C Graham Regional Molecular Genetics Laboratory, Belfast APC-Associated polyposis conditions Familial adenomatous polyposis (FAP) >100 adenomatous colonic polyps Often thousands of colonic polyps Polyps present throughout the colon Early age of onset Germline mutations in APC gene Autosomal dominant Attenuated FAP (AFAP) Fewer colonic polyps (<100) Later age of onset APC Gene AFAP Classic FAP 436 1596 AFAP MUTATION CLUSTER REGION 1061 (aa) Ex 1 500 3 5 1000 9/9a 10 11 12 13 14 1309 5bp mutation Hot Spots 2843 1500 2000 15 ARMADILLO REPEATS B-CATENIN BINDING DOMAIN FUNCTONAL DOMAINS MICROTUBULE BINDING DOMAIN B-CATENIN DEGRADATION DOMAIN EB1 BINDING DOMAIN Grady and Markowitz APC Mutations Mutation Type Small deletions Missense/nonsense Small insertions Gross deletions Splicing Small indels Regulatory No. Mutations (%) 356 (41%) 235 (27%) 131 (15%) 54 (6%) 49 (5%) 17 (2%) 3 (<1%) Molecular genetic testing using range of techniques including MLPA, PTT and DNA sequencing Mutation detection rate – up to 90% Case 1 ? II:1 9 sibs II:2 II:3 II:4 II:5 II:6 II:7 III:1 • Age 47- Adenocarcinoma • Colonoscopy - > 100 + polyps located proximal and distal to tumour • Suspected family history of colon cancer on maternal side • APC Ex 15 PTT - Negative • APC Ex 1-14 screen c.1409-5A>G in intron 10 APC Gene AFAP 436 (aa) Ex 1 1 FAP with CHRPE 1596 1000 1500 500 3 5 9/9a 10 11 12 13 14 ARMADILLO REPEATS AFAP 2000 2843 15 Exon 11 G c.1409-5 A>G CCCTTTTTAA TTAG GGGGACTAC A -Splice acceptor site • Fruitfly and SpliceSiteFinder prediction programmes predicted use of alternative splice site. Score – 80.6 • Previously reported in large European study – Pathogenicity undetermined Friedl & Aretz, 2005 Molecular analysis c.1409-5A>G DNA cDNA Splice acceptor site G CCCTTTTTAA A TTAG GGGGACTAC Intron 10 Ex 11 Alternative splice site CCCTTTTTAAGTTAG GGGGACTAC RNA 4bp insertion – (p.G470Vfsx15) AATGAACTAGTTAGGGGGACTACAGGC,,,,TGA Term Ex11 Ex10 N N M 254bp 250bp Case 2 Breast Ca II:1 II:2 ? Colon Ca II:3 Jejunal Ca ? Colon Ca III.2 • Age 55 - Carcinoma of sigmoid colon • Age 62 - Multiple polyps throughout colon II:4 II:5 II:6 Melanoma • MYH gene - Negative • APC Ex 15 PTT - Negative • APC Ex 1-14 Screen c.423 G>T (p.R141S) Exon 4 APC gene Case 2 Breast Ca II:1 II:2 II:3 AFAP II:4 II:5 II:6 AFAP III:2 III:3 AFAP III:4 AFAP c.423 G>T Splicing mutation PRESENT III:5 APC Gene AFAP (aa) 1 AFAP 500 345 9/9a 10 11 12 13 14 1000 1500 2000 15 c.423G>T p.R141S • Conserved amino acid sequence • Predicted to disrupt splice-site – (Fruitfly and SpliceSiteFinder and prediction programmes) • Reported by Aretz et al., 2004. Human Mutation 24(5): 370-80 Molecular analysis Intron 3 DNA Exon 4 c.423G>T AAGAGAG GTCAATTGCTTCTTGCT T Ex3 Ex4 Ex5 109bp RNA II.2 II.2 II.4 III.3 III.3 N Ex3 301 192 Ex3 Ex4 Ex5 Ex5 Exon skipping confirmed by sequence analysis of the cDNA product across junction. Summary Case 1 – Atypical FAP c.1409-5 A>G mutation – Splice-site prediction programmes RNA studies Selection of an alternative splice site. Case 2 – AFAP c.423 G>T (p.R141S) missense mutation – Amino acid conservation Segregation with disease Splice site prediction programmes RNA studies Exon skipping possibly due to possible effect on exonic splicing enhancer motifs (ESEs). (Aretz et al., 2004). To conclude… Splicing mutations can cause FAP and warrant further investigation CMGS Best Practice Guidelines on the interpretation and reporting of unclassified variants